T-type calcium channel expression and function in the diseased heart

Channels

Volumn 4, Issue 6, 2010, Pages

  Cribbs, Leanne L ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Cardiac; Disease; Expression; Hypertrophy; Regulation; T type

Indexed keywords

CALCIUM CHANNEL T TYPE; EFONIDIPINE; MIBEFRADIL; NITRENDIPINE; HORMONE;

CONGESTIVE CARDIOMYOPATHY; HEART ARRHYTHMIA; HEART DISEASE; HEART FAILURE; HEART HYPERTROPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE INFARCTION; HUMAN; HYPOXIA; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULMONARY HYPERTENSION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; CALCIUM SIGNALING; CARDIOMEGALY; CELL HYPOXIA; CELL MEMBRANE POTENTIAL; CHANNEL GATING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HEART MUSCLE CELL; METABOLISM; PATHOPHYSIOLOGY;

ANIMALIA;

ANIMALS; CALCIUM CHANNELS, T-TYPE; CALCIUM SIGNALING; CARDIOMEGALY; CELL HYPOXIA; GENE EXPRESSION REGULATION; HEART DISEASES; HEART FAILURE; HORMONES; HUMANS; ION CHANNEL GATING; MEMBRANE POTENTIALS; MYOCYTES, CARDIAC; TRANSCRIPTION, GENETIC;

EID: 78650823466     PISSN: 19336950     EISSN: 19336969     Source Type: Journal    
DOI: 10.4161/chan.4.6.12870     Document Type: Review

References (70)

1. Perez-Reyes E. Molecular physiology of low-voltage-activated T-type calcium channels. Physiol Rev 2003; 83:117-61. (Pubitemid 36459879)
2. 2+ channels in fetal and diseased heart. J Pharmacol Sci 2005; 99:205-10.
3. 2+ channels in the heart. Cell Calcium 2006; 40:205-20.
4. 2+ channels in the heart. J Mol Cell Cardiol 2010; 48:65-70.
5. Bers DM. Excitation-Contraction Coupling and Cardiac Contractile Force. Dordrecht: Kluwer Academic Publishers, 1991.
6. Leuranguer V, Monteil A, Bourinet E, Dayanithi G, Nargeot J. T-type calcium currents in rat cardiomyocytes during postnatal development: contribution to hormone secretion. Am J Physiol 2000; 279:2540-8.
7. 2+ channel in murine hearts during the embryonic period. Am J Physiol Heart Circ Physiol 2004; 286:2257-63.
8. V3.1 during differentiation of embryonic stem cells to cardiac cell lineage. Circ J 2005; 69:284-1289.
9. Hagiwara N, Irisawa H, Kameyama M. Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Physiol 1988; 395:233-53.
10. Doerr T, Denger R, Trautwein W. Calcium currents in single SA nodal cells of the rabbit heart studied with action potential clamp. Pflugers Arch 1989; 413:599-603.
11. 2+ channel inhibitors in the pacemaker depolarization in rabbit sino-atrial nodal cells. Gen Pharmacol 1995; 26:581-7.
12. V3.1 (α1G) controls von Willebrand factor secretion in rat pulmonary microvascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 2007; 292:833-44.
13. 2+ release contributes to automaticity in cat atrial pacemaker cells. J Physiol 2000; 524.2:415-22.
14. Perez-Reyes E, Cribbs LL, Daud A, Lacerda AE, Barclay J, Williamson MP, et al. Molecular characterization of a neuronal low voltage-activated T-type calcium channel. Nature 1998; 391:896-900. (Pubitemid 28157667)
15. Cribbs LL, Lee JH, Daud A, Satin J, Barclay J, Williamson MP, et al. Cloning and characterization of α1H from human heart, a member of the T-type calcium channel gene family. Circ Res 1998; 83:103-9.
16. Lee JH, Daud A, Cribbs LL, Lacerda AE, Pereverzev A, Klockner U, et al. Cloning and expression of a novel member of the low voltage-activated T-type calcium channel family. J Neurosci 1999; 19:1912-21. (Pubitemid 29133369)
17. 2+ current is expressed in hypertrophied adult feline left ventricular myocytes. Circ Res 1993; 73:777-82.
18. 2+ channels are abnormal in genetically determined cardiomyopathic hamster hearts. Circ Res 1994; 75:149-55.
19. 2+ current in heart cells of the cardiomyopathic hamster. Mol Cell Biochem 1997; 176:199-204.
20. 2+ channel gene and current in post-infarction remodeled rat left ventricle. Card Res 2000; 46:442-9.
21. Schmitt R, Clozel JP, Iberg N, Buhler FR. Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel. Arterioscler Thromb Vasc Biol 1995; 15:1161-5.
22. Sandmann S, Spitznagel H, Chung O, Xia QG, Illner S, Janichen G, et al. Effects of the calcium channel antagonist mibefradil on haemodynamic and morphological parameters in myocardial infarction-induced cardiac failure in rats. Cardiovasc Res 1998; 39:339-50.
23. Mocanu M, Gadgil S, Yellon D, Baxter G. Mibefradil, a T-type and L-type calcium channel blocker, limits infarct size through a glibenclamide-sensitive mechanism. Cardiovasc Dribs Ther 1999; 13:115-22. (Pubitemid 29224836)
24. Arh M, Budihna M. Comparison of effects of nitrendipine, lacidipine and mibefradil on postischaemic myocardial damage in isolated rat hearts. Pfluegers Arch-Eur J Physiol 2000; 440:149-50.
25. Sandmann S, Claas R, Cleutjens J, Daemen M, Unger T. Calcium channel blockade limits cardiac remodeling and improves cardiac function in myocardial infarction-induced heart failure in rats. J Cardiovasc Pharmacol 2001; 37:64-77.
26. Villame J, Massicotte J, Jasmin G, Dumont L. Effects of mibefradil, a T- and L-type calcium channel blocker, on cardiac remodeling in the UM-X7.1 cardiomyopathic hamster. Cardiovasc Drugs Ther 2001; 15:41-8.
27. Mozaffari M, Patel C, Schaffer S. Mechanisms underlying afterload-induced exacerbation of myocardial infarct size. Role of T-type Ca2+ channel. Hypertension 2006; 47:912-9. (Pubitemid 44297563)
28. Viana F, Van Den Bosch L, Missiaen L, Vandenberghe W, Droogmans G, Nilius B, Robberecht W. Mibefradil (Ro 40m5967) blocks multiple types of voltage-gated calcium channels in cultured rat spinal motoneurones. Cell Calcium 1997; 22:299-311.
29. Perchenet L, Clement-Chomienne O. Characterization of mibefradil block of the human heart delayed rectifier hKV1.5. J Pharmacol Exp Ther 2000; 295:771-8.
30. Xu XP, Best PM. Increase in T-type calcium current in atrial myocytes from adult rats with growth hormone-secreting tumors. Proc Natl Acad Sci USA 1990; 87:4655-9.
31. Huang C, Hao L, Buetow D. Insulin-like growth factor-I gene expression precedes left ventricular cardiomyocyte hypertrophy in a rapidly hypertrophying rat model system. Cell Biochem Funct 2002; 21:355-61.
32. Matthews K, Devlin G, Conaglen J, Stuart S, Mervyn Aitken W, Bass J. Changes in IGFs in cardiac tissue following myocardial infarction. J Endocrinol 1999; 163:433-45. (Pubitemid 30033739)
33. 2+ channel and insulin-like growth factor genes in rat atria. Am J Physiol Heart Circ Physiol 2005; 288:829-38.
34. Bonvallet R, Rougier O. Existence of two calcium currents recorded at normal calcium concentrations in single frog atrial cells. Cell Calcium 1989; 10:499-508.
35. Ferron L, Capuano V, Ruchon Y, Deroubaix E, Coulombe A, Renaud JF. Angiotensin II Signaling Pathways Mediate Expression of Cardiac T-Type Calcium Channels. Circ Res 2003; 93:1241-8.
36. 2+ current in heart cells. Peptides 2005; 26:1410-7.
37. 2+ channel is required for pressure overload-induced cardiac hypertrophy in mice. Circ Res 2009; 104:522-30.
38. Furukawa T, Ito H, Nitta J, Tsujino M, Adachi S, Hiroe M, et al. Endothelin-1 enhances calcium entry through T-type calcium channels in cultured neonatal rat ventricular myocytes. Circ Res 1992; 71:1242-53.
39. Izumi T, Kihara Y, Sarai N, Yoneda T, Iwanaga Y, Inagaki K, et al. Reinduction of T-type calcium channels by endothelin-1 in failing hearts in vivo and in adult rat ventricular myocytes in vitro. Circulation 2003; 108:2530-5. (Pubitemid 37444417)
40. Rossier MF, Python M, Maturana AD. Contribution of mineralocorticoid and glucocorticoid receptors to the chronotropic and hypertrophic actions of aldosterone in neonatal rat ventricular myocytes. Endocrinology 2010; 151:2777-87.
41. Lalevee N, Rebsamen MC, Barrere-Lemaire S, Perrier E, Nargeot J, Benitah JP, Rossier MF. Aldosterone increases T-type calcium channel expression and in vitro beating frequency in neonatal rat cardiomyocytes. Cardiovascular Research 2005; 67:216-24.
42. Rossier MF, Lenglet S, Vetterli L, Python M, Maturana A. Corticosteroids and redox potential modulate spontaneous contractions in isolated rat ventricular cardiomyocytes. Hypertension 2009; 52:721-8.
43. V3.2 in the chronotropic action of corticosteroids in isolated rat ventricular myocytes. Endocrinology 2009; 150:3726-34.
44. V3.1 channels expression by synthetic glucocorticoid dexamethasone in neonatal cardiac myocytes. Mol Cell Biochem 2009; 320:173-83.
45. BenMohamed F, Ruchon Y, Capuano V, Renaud JF. Identification of functional corticosteroid response elements involved in regulation of CACNA1G expression in cardiac myocytes. Molecular and Cellular Biochemistry: Springer Netherlands 2010; 47-51.
46. V3.2 T-type calcium channel via extracellularly regulated kinase pathway in cardiomyocytes. Endocrinology 2009; 150:879-88.
47. Del Toro R, Levitsky KL, Lopez-Barneo J, Chiara MD. Induction of T-type calcium channel gene expression by chronic hypoxia. J Biol Chem 2003; 278:22316-24.
48. Carabelli V, Marcantoni A, Comunanza V, de Luca A, Diaz J, Borges R, Carbone E. Chronic hypoxia upregulates alpha1H T-type channels and low-threshold catecholamine secretion in rat chromaffin cells. J Physiol 2007; 584:149-65.
49. 2+ channel expression and its role in rat chromaffin cell responsiveness to acute hypoxia. J Physiol 2009; 587:1917-29.
50. 2 sensing in chromaffin cells: new duties for T-type channels. J Physiol 2009; 587:1859-60.
51. Pluteanu F, Cribbs L. T-type calcium channels are regulated by hypoxia/reoxygenation in ventricular myocytes. Am J Physiol Heart Circ Physiol 2009; 297:1304-13.
52. 2+ channel. Am J Physiol Cell Physiol 2010; 299:289-97.
53. Kuwahara K, Saito Y, Takano M, Arai Y, Yasuno S, Nakagawa Y, et al. NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function. EMBO J 2003; 22:6310-21.
54. 2+ channels in neonatal rat heart. J Mol Cell Cardiol 2007; 42:1045-53.
55. D'Alonzo G, Barst R, Ayres S, Bergofsky E, Brundage B, Detre K, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991; 115:343-9.
56. Sandoval J, Bauerle O, Palomar A, Gomez A, Martinez-Guerra M, Beltran M, Guerrero M. Survival in primary pulmonary hypertension. Validation of a prognostic equation. Circulation 1994; 89:1733-44.
57. Bogaard H, Abe K, Noordegraaf A, Voelkel N. The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest 2009; 135:794-804.
58. Takebayashi S, Li Y, Kaku T, Inagaki S, Hashimoto Y, Kimura K, et al. Remodeling excitation-contraction coupling of hypertrophied ventricular myocytes is dependent on T-type calcium channels expression. Biochem Biophys Res Commun 2006; 345:766-73. (Pubitemid 44226340)
59. 2+ channels in rat right atrium with monocrotaline-induced pulmonary hypertension. Circ J 2009; 73:256-63.
60. 2+ Channel Blockade Prevents Sudden Death in Mice With Heart Failure. Circulation 2009; 120:743-52.
61. Zhou Z, Lipsius SL. T-type calcium current in latent pacemaker cells isolated from cat right atrium. J Mol Cell Cardiol 1994; 26:1211-9.
62. 1G T-type calcium channels. Circ Res 2006; 98:1422-30.
63. 2+ channels have different effects on myocyte contractility and induce unique cardiac phenotypes. Circ Res 2008; 108:185611.
64. 2+ current antagonizes cardiac hypertrophy through a NOS3-dependent mechanism in mice. J Clin Invest 2009; 119:3787-96.
65. Fiedler B, Lohmann SM, Smolenski A, Linnemuller S, Pieske B, Schroder F, et al. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes. Proc Natl Acad Sci USA 2002; 99:11363-8.
66. 2+ channels. Science 2003; 302:1416-8.
67. 2+ channel blockers. Life Sci 2008; 82:554-60.
68. V3.2 in the chronotropic action of corticosteroids in isolated rat ventricular myocytes. Endocrinology 2009; 150:3726-34.
69. V3.2 T-type calcium channel mediate voltage-dependent facilitation and associate with cardiac hypertrophy and development. Channels 2010; 4:375-89.
70. V3.1d) in developing mouse heart. Circ Res 2001; 88:403-7.